PORCILIS ERY + PARVO

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

ERYSIPELOTHRIX RHUSIOPATHIAE STRAIN M2 (SEROTYPE 2)

Mevcut itibaren:

Intervet Ireland Limited

ATC kodu:

QI09AL01

INN (International Adı):

ERYSIPELOTHRIX RHUSIOPATHIAE STRAIN M2 (SEROTYPE 2)

Doz:

Unknown

Farmasötik formu:

Suspension for Injection

Reçete türü:

LM-Licensed Merchant

Terapötik grubu:

Porcine

Terapötik alanı:

Inactivated Porcine parvovirus vaccine + inactivated Erysipelothrix vaccine

Terapötik endikasyonlar:

Immunological - Inactivated vaccine

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2001-05-04

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis Ery + Parvo
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCES:
Per dose of 2 ml:
- Inactivated porcine parvovirus (PPV) strain 014:
552 EU as determined in the final product by antigenic mass
ELISA
- Inactivated lysed antigen concentrate of _Erysipelothrix rhusiopathiae _strain M2 (serotype 2):
1 pig protective dose
(ppd) as measured in the Ph. Eur. potency test
Adjuvant:
dl-
Tocopherol acetate 150 mg
Preservative:
Formaldehyde 0.02 - 0.05%
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (sows and gilts)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of sows and gilts to reduce clinical signs and lesions caused by erysipelas disease and to
prevent or reduce mortality and clinical signs of parvovirus infection on embryos and foetuses during pregnancy.
4.3 CONTRAINDICATIONS
None.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 05/11/2015_
_CRN 7022311_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Only healthy animals should be vaccinated.
After vaccination with Porcilis Ery + Parvo, animals may seroconvert and detectable levels of antibody to PPV may
persist.
PPV infection is not the only cause of reproductive failure in pigs.
A good immune response is reliant on the reaction of an immunogenic agent and a fully competent immune system.
Immunogenicity of the vaccine antigen will be reduced by poor storage or inappropriate administration.
Immunocompetence of the animal may be compromised by a variety of factors including poor health, nutritional